Posts

Violet CEO on measuring clinician inclusiveness: ‘It’s ...

Violet trains clinicians on identity-centered health care, particularly for pati...

STAT+: 3 FDA staffers to watch in 2024

The FDA has a lot on its plate in 2024 with the reorganizations of its food cent...

Opinion: People with food insecurity deserve better nut...

Food literacy skills and nutrition knowledge make a lifelong impact in improving...

STAT+: 3 issues to watch in pharma in 2024

What are the issues to watch in pharma in 2024? The past is likely prologue.

STAT+: Complications spiked 25% in hospitals bought by ...

Adverse events at hospitals like falls and infections spiked 25% after private e...

Opinion: Does food as medicine help patients with diabe...

Does food as medicine help patients with diabetes? Here’s what a new clinical tr...

STAT+: With Biden finalizing an Apple Watch ban, Apple ...

President Biden finalized an import ban of latest Apple Watches after the ITC de...

STAT+: Bristol Myers will pay $4.1 billion for cancer s...

Bristol Myers Squibb will pay $4.1 billion for RayzeBio, buying into the fast-gr...

STAT+: 3 CRISPR advances to watch in 2024

Approval of the first CRISPR-based medicine paves the way for in vivo therapies,...

STAT+: New weight loss drugs have proven their effectiv...

A team of researchers will soon launch a study driven by a pressing question in ...

STAT+: 3 medtech trends to watch in 2024

STAT looks at the forces that shaped the medical devices industry last year, and...

In situ characterization reveals different dehydrogenat...

They published their work on Dec. 20 in Energy Material Advances. Credit: Wen Zh...

Virtual care works best when patients see their own fam...

Toronto, ON, December 27, 2023 – Compared to patients who had a virtual visit wi...

A study of the genetics of pericarditis increases under...

A study of the genetics of pericarditis increases understanding of newly approve...

Scientists use organoid model to identify potential new...

A drug screening system that models cancers using lab-grown tissues called organ...

Asian Fund for Cancer Research announces Degron Therape...

The Asian Fund for Cancer Research (AFCR) is pleased to announce that Degron The...